PITTSBURGH, July 12, 2019 - Living-donor liver transplant offers numerous advantages over deceased-donor transplant, including better three-year survival rates for patients and lower costs, according to new research from the UPMC Thomas E. Starzl Transplantation Institute and the University of Pittsburgh School of Medicine.
Many burn victims suffer acute kidney injury (AKI), but early recognition of AKI remains challenging. Now an Artificial Intelligence / Machine Learning (AI/ML) model developed at UC Davis Health and reported in a new study can predict acute kidney injury quicker and more accurately than ever.
Breast cancer is the leading cause of cancer-related death among women. It is also difficult to diagnose. Nearly one in 10 cancers is misdiagnosed as not cancerous, meaning that a patient can lose critical treatment time. On the other hand, the more mammograms a woman has, the more likely it is she will see a false positive result. After 10 years of annual mammograms, roughly two out of three patients who do not have cancer will be told that they do and be subjected to an invasive intervention, most likely a biopsy.
PHILADELPHIA (July 12, 2019) - Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge. Now, a new study from the University of Pennsylvania School of Nursing (Penn Nursing) illustrates how certain health system constraints present barriers to effective care and impact outcomes for patients with high social risks.
Efforts to shift away from fossil fuels and replace oil and coal with renewable energy sources can help reduce carbon emissions but do so at the expense of increased inequality, according to a new Portland State University study.
Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, a new study shows.
Scientists discovered that when the breast cancer drug palbociclib was combined with the lung cancer drug crizotinib, the two-drug combination was significantly more effective against cancer cells in the laboratory than either drug used on its own.
DURHAM, N.C. - New data from a two-year Duke Health trial suggests when it comes to cutting your risk for killer ailments such as diabetes and heart disease, there's always room for improvement.
In adults already at a healthy weight or carrying just a few extra pounds, cutting around 300 calories a day significantly improved already good levels of cholesterol, blood pressure, blood sugar and other markers. The findings of the randomized, controlled trial of 218 adults under age 50 are described in a July 11 article in the journal The Lancet Diabetes & Endocrinology.
Patients with chronic kidney disease (CKD) have a high prevalence of uncontrolled hypertension and diabetes, as well as statin use below the recommended guidelines for cholesterol control, according to a study by researchers at UC San Francisco.
While researchers have a basic understanding of how primary cancer cells grow, less is known about metastasis, the deadly process by which cancers spread. A team led by Dr. Paul Krebsbach, dean of UCLA's School of Dentistry and professor of periodontics, has found that mEAK-7, a gene they discovered last year, may play a significant role in cancer metastasis, at least in lung cancers.
The relapse of brain tumors after therapy is driven by cancer stem cells that were not affected by the treatment. In mouse models of glioblastoma, scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) were now looking for molecular markers that specifically characterize brain tumor stem cells. They identified an enzyme that is responsible for the threatening stem cell properties of glioblastoma and at the same time represents a possible "Achilles heel" where cancer stem cells could be vulnerable.
New research by neuroscientists at the University of Chicago shows that the posterior parietal cortex (PPC), an area of the brain often associated with planning movements and spatial awareness, also plays a crucial role in making decisions about images in the field of view.
A new type of therapeutic food, specifically designed to repair the gut microbiomes of malnourished children, is superior to standard therapy in an initial clinical trial conducted in Bangladesh.
High-risk pregnancies occur frequently and may be caused by various factors. It is estimated that 10 to 20% of pregnant women miscarry during their first trimester of pregnancy. Slow fetal growth may also arise as a result of maternal infection with certain microbes, parasites or viruses (such as toxoplasmosis or infection with rubella virus, cytomegalovirus, herpes or Zika) or because of genetic or autoimmune diseases.
PHILADELPHIA - Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy - meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments - almost tripled the median progression-free survival (PFS) compared to the historical average. Research from the Abramson Cancer Center at the University of Pennsylvania found the average PFS of study participants was 19.1 months, compared to 6.6 months. JAMA Oncology published the findings today.
New research raises questions as to whether too many infants are getting tongue-tie and lip tether surgery (also called frenulectomy) to help improve breastfeeding, despite limited medical evidence supporting the procedure.